Medical Condition News

RSS

Latest study recommends accelerated radiotherapy for un-resected NSCLC patients

Radiotherapy with or without chemotherapy is increasingly being used in the curative treatment for un-resected non-small cell lung cancer (NSCLC). But, until now, researchers had not looked at the cost-effectiveness of the treatment.

5 Sep 2013

FDA grants Priority Review status to Takeda's investigational drug vedolizumab for ulcerative colitis

Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., today announced that the United States Food and Drug Administration has granted Priority Review status for the Biologics License Application for its new investigational drug vedolizumab for the treatment of adults with moderately to severely active ulcerative colitis.

5 Sep 2013

People with CVD more likely to take preventive medicines when combined in one pill

People are much more likely to take preventive medicines if they're combined in one pill, an international study has found. The findings are published today in the Journal of the American Medical Association.

5 Sep 2013

Neurodyn acquires all assets related to new drug candidate Memogain from Galantos Pharma

Neurodyn Inc. announced today that it has acquired from Galantos Pharma GmbH, Mainz, Germany all assets related to their Alzheimer's prescription drug candidate - Memogain. Memogain has completed an extensive preclinical development program and is ready to proceed into Phase 1 clinical trials in late 2013. The terms of the acquisition were not disclosed.

5 Sep 2013

Sanofi, POZEN ink license agreement to commercialize PA8140 and PA32540 tablets in US

Sanofi US and POZEN Inc. announced the signing of an exclusive license agreement for the commercialization of POZEN's proprietary, investigational, coordinated-delivery tablets combining immediate-release omeprazole, a proton pump inhibitor, and enteric-coated aspirin in a single tablet ("PA"), PA8140 and PA32540.

5 Sep 2013

Sirt1 Protein, Not Calorie Restriction, Extends Life Span

...

4 Sep 2013

Boosting Your Brain Power With Sleep

...

4 Sep 2013

Study identifies new tool to accurately analyze mtDNA deletions associated with diseases, aging

A study published today in Aging Cell identifies a new tool to accurately analyze extremely rare mitochondrial DNA deletions associated with a range of diseases and disorders as well as aging. This approach, which relies on Droplet Digital PCR (ddPCR-) technology, will help researchers explore mtDNA deletions as potential disease biomarkers.

4 Sep 2013

Indicators of poor preoperative health predict risk of major medical complications

For older adults undergoing surgery for spinal stenosis, some simple indicators of poor preoperative health predict a high risk of major medical complications, reports a study in the September 1 issue of Spine. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

4 Sep 2013

Endo, BDSI complete interim analyses of Phase III trials for BEMA Buprenorphine

Endo Pharmaceuticals Inc., a subsidiary of Endo Health Solutions Inc., and BioDelivery Sciences International, Inc. announced today that the companies have completed interim analyses of both the opioid naive and opioid experienced Phase III trials for BEMA Buprenorphine.

4 Sep 2013

Free reference and lifestyle tool now available for people affected by paralysis

For the first time, individuals living with paralysis and their caregivers can access the comprehensive Paralysis Resource Guide digitally on their smartphone, Nook, iPad or Kindle. The third edition of this vital resource, compiled and distributed by the Christopher & Dana Reeve Foundation Paralysis Resource Center, is a free reference and lifestyle tool for people affected by paralysis.

4 Sep 2013

University of Leeds to study mechanism of Prana’s PBT434 in animal models of Parkinson’s disease

Prana Biotechnology today announced that Parkinson’s UK has awarded £150,000 (AU$260,000) to The University of Leeds to study the mechanism of action of PBT434.

4 Sep 2013

Research finding provides blueprint for understanding how the brain communicates with itself

During a normal conversation, your brain is constantly adjusting the volume to soften the sound of your own voice and boost the voices of others in the room.

4 Sep 2013

National Sleep Foundation releases 2013 International Bedroom Poll

The National Sleep Foundation released its first international poll today, the 2013 International Bedroom Poll, comparing sleep times, attitudes, habits and bedtime routines of those in the United States, Canada, Mexico, the United Kingdom, Germany and Japan between the ages of 25 and 55 years old.

4 Sep 2013

Combination of body type, landing techniques may be responsible for ACL injuries

Women are two to eight times more likely than men to suffer a debilitating tear of the anterior cruciate ligament (ACL) in the knee and a new study suggests that a combination of body type and landing techniques may be to blame.

4 Sep 2013

High sensitive troponin test may help doctors improve diagnosis in patients with heart attack

Abbott (NYSE: ABT) announced today promising preliminary results from a study presented at the ESC Congress 2013, suggesting that its high sensitive troponin test may help doctors improve the diagnosis and prognosis of patients presenting with symptoms of a heart attack.

4 Sep 2013

Study looks for molecular changes in genome caused by multiple sclerosis

The National Institutes of Health (NIH) awarded Benaroya Research Institute at Virginia Mason (BRI) a $1.9 million grant to find marks in the human genome which can explain why some white blood cells cause damage to the spinal cord and brain in multiple sclerosis (MS).

4 Sep 2013

Research on long-lived proteins may lead to better understanding of molecular basis of aging

Proteins are the chief actors in cells, carrying out the duties specified by information encoded in our genes. Most proteins live only two days or less, ensuring that those damaged by inevitable chemical modifications are replaced with new functional copies.

4 Sep 2013

RVX-208 drug fails to increase good cholesterol levels in ASSURE trial

Patients with coronary artery disease and low levels of "good cholesterol - or high-density lipoprotein - who were treated with a drug designed to increase HDL levels and reduce coronary plaque build-up, experienced no better results than those treated with placebo, according to research conducted by the Cleveland Clinic Coordinating Center for Clinical Research.

4 Sep 2013

Aliskiren does not slow progression of coronary atherosclerosis in prehypertension patients

Among patients with prehypertension and coronary artery disease, use of the renin (an enzyme secreted by the kidneys) inhibitor aliskiren, compared with placebo, did not result in improvement or slowing in the progression of coronary atherosclerosis, according to a study published by JAMA. The study is being released early online to coincide with its presentation at the European Society of Cardiology Congress 2013.

4 Sep 2013

Medical Condition News

Latest study recommends accelerated radiotherapy for un-resected NSCLC patients

FDA grants Priority Review status to Takeda's investigational drug vedolizumab for ulcerative colitis

People with CVD more likely to take preventive medicines when combined in one pill

Neurodyn acquires all assets related to new drug candidate Memogain from Galantos Pharma

Sanofi, POZEN ink license agreement to commercialize PA8140 and PA32540 tablets in US

Sirt1 Protein, Not Calorie Restriction, Extends Life Span

Boosting Your Brain Power With Sleep

Study identifies new tool to accurately analyze mtDNA deletions associated with diseases, aging

Indicators of poor preoperative health predict risk of major medical complications

Endo, BDSI complete interim analyses of Phase III trials for BEMA Buprenorphine

Free reference and lifestyle tool now available for people affected by paralysis

University of Leeds to study mechanism of Prana’s PBT434 in animal models of Parkinson’s disease

Research finding provides blueprint for understanding how the brain communicates with itself

National Sleep Foundation releases 2013 International Bedroom Poll

Combination of body type, landing techniques may be responsible for ACL injuries

High sensitive troponin test may help doctors improve diagnosis in patients with heart attack

Study looks for molecular changes in genome caused by multiple sclerosis

Research on long-lived proteins may lead to better understanding of molecular basis of aging

RVX-208 drug fails to increase good cholesterol levels in ASSURE trial

Aliskiren does not slow progression of coronary atherosclerosis in prehypertension patients

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Latest News